N-(1H-1,3-BENZODIAZOL-2-YL)-3-CYANOBENZAMIDE
UNII FEE9ACP9JJ

Substance Identification & Data

This profile provides standardized clinical and technical data for N-(1h-1,3-benzodiazol-2-yl)-3-cyanobenzamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FEE9ACP9JJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 850091-27-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

FEE9ACP9JJ

CAS Registry Number

850091-27-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

N-(1H-1,3-BENZODIAZOL-2-YL)-3-CYANOBENZAMIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C15H10N4O

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

JSWLIGOCNPPDTR-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

2635761

Unique identification number in the NCBI database of chemical substances.

Substance Type

N-(1H-1,3-benzodiazol-2-yl)-3-cyanobenzamide

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1ccc2c(c1)[nH]c(n2)NC(=O)c3cccc(c3)C#N

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for N-(1h-1,3-benzodiazol-2-yl)-3-cyanobenzamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.